References
- Giannelli FR. 2020. Major depressive disorder. JAAPA 33: 19-20.
- Tao X, Chi O, Delaney PJ, Li L, Huang J. 2021. Detecting depression using an ensemble classifier based on quality of life scales. Brain Inform. 8: 2.
- Dhama K, Sharun K, Gugjoo MB, Tiwari R, Alagawany M, Iqbal Yatoo M, et al. 2023. A comprehensive review on chemical profile and pharmacological activities of Ocimum basilicum. Food Rev. Int. 39: 119-147.
- Murrough JW, Abdallah CG, Mathew SJ. 2017. Targeting glutamate signalling in depression: progress and prospects. Nat. Rev. Drug Discov. 16: 472-486.
- Nisca A, stefanescu R, Stegarus DI, Mare AD, Farczadi L, Tanase C. 2021. Phytochemical profile and biological effects of spruce (Picea abies) bark subjected to ultrasound assisted and microwave-assisted extractions. Plants (Basel) 10: 870.
- Boivin M, Bourdeau N, Barnabe S, Desgagne-Penix, I. 2021. Black spruce extracts reveal antimicrobial and sprout suppressive potentials to prevent potato (Solanum tuberosum L.) losses during storage. J. Agric. Food Chem. 5: 100187.
- Tang M, Ai Y, Song N, Geng L, Ren L, Zhu S, et al. 2023. Chemical composition and hypnotic effect of Picea mariana essential oils. J. Essent. Oil Bear. Pl. 26: 1-16.
- accouch R, Rascol E, Stoklosa K, Alves ID. 2022. The role of the lipid environment in the activity of G protein coupled receptors. Biophys. Chem. 285: 106794.
- Tafet GE, Nemeroff CB. 2020. Pharmacological treatment of anxiety disorders: the role of the HPA axis. Front. Psychiatry 11: 443.
- De Gregorio D, Enns JP, Nunez NA, Posa L, Gobbi G. 2018. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: mechanism of action and potential therapeutic applications in mood disorders. Prog. Brain Res. 242: 69-96.
- Malcolm B, Thomas K. 2022. Serotonin toxicity of serotonergic psychedelics. Psychopharmacology (Berl) 239: 1881-1891.
- Jiang Y, Peng T, Gaur U, Silva M, Little P, Chen Z, et al. 2019. Role of corticotropin releasing factor in the neuroimmune mechanisms of depression: examination of current pharmaceutical and herbal therapies. Front. Cell. Neurosci. 13: 290.
- Kim JE, Chae S, Kim S, Jung YJ, Kang MG, Heo W, et al. 2021. Cerebellar 5HT-2A receptor mediates stress-induced onset of dystonia. Sci. Adv. 7: eabb5735.
- Machaalani R, Chen H. 2018. Brain derived neurotrophic factor (BDNF), its tyrosine kinase receptor B (TrkB) and nicotine. Neurotoxicology 65: 186-195.
- Shahamat Z, Abbasi-Maleki S, Mohammadi Motamed S. 2016. Evaluation of antidepressant-like effects of aqueous and ethanolic extracts of Pimpinella anisum fruit in mice. Avicenna J. Phytomed. 6:322-328.
- Ghaderi H, Rafieian M, Nezhad HR. 2018. Effect of hydroalcoholic Cinnamomum zeylanicum extract on reserpine-induced depression symptoms in mice. Pharmacophore 9: 35-44.
- Poleszak E, Szopa A, Bogatko K, Wyska E, Wosko S, Swiader K, et al. 2019. Antidepressant-like activity of typical antidepressant drugs in the forced swim test and tail suspension test in mice is augmented by DMPX, an adenosine A 2A receptor antagonist. Neurotox. Res. 35: 344-352.
- Simmons WK, Burrows K, Avery JA, Kerr KL, Taylor A, Bodurka J, et al. 2020. Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states. Mol. Psychiatry 25: 1457-1468.
- Akilimali PZ, Musumari PM, LundimuTugirimana P, Beya P, Mutombo FJ, Kayembe PK, et al. 2016. Depressive symptoms, loss of appetite and under nutrition among treated HIV patients: a cross sectional study in Goma, the Democratic Republic of Congo. J. Nutr. Health Food Sci. 4: 1-10.
- Kraeuter AK, Guest PC, Sarnyai Z. 2019. The forced swim test for depression-like behavior in rodents. Methods Mol. Biol. 1916: 75-80.
- Fitzgerald PJ, Yen JY, Watson BO. 2019. Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test. PLoS One 14: e0215554.
- Ruiz NAL, Del Angel DS, Olguin HJ, Silva ML. 2018. Neuroprogression: the hidden mechanism of depression. Neuropsychiatr. Dis. Treat. 14: 2837-2845.
- Lim DW, Park J, Jung J, Kim SH, Um MY, Yoon M, Kim YT, et al. 2020. Dicaffeoylquinic acids alleviate memory loss via reduction of oxidative stress in stress-hormone-induced depressive mice. Pharmacol. Res. 161: 105252.
- Won E, Kim YK. 2016. Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression. Curr. Neuropharmacol. 14: 665-673.
- Fung TC, Olson CA, Hsiao EY. 2017. Interactions between the microbiota, immune and nervous systems in health and disease. Nat. Neurosci. 20: 145-155.
- Francezon N, Stevanovic T. 2017. Chemical composition of essential oil and hydrosol from Picea mariana bark residue. BioResources 1: 2635-2645.
- Alvarez-Chavez BJ, Godbout S, Le Roux E, Palacios JH, Raghavan V. 2019. Bio-oil yield and quality enhancement through fast pyrolysis and fractional condensation concepts. Biofuel Res. J. 6: 1054-1064.
- Strawbridge R, Javed RR, Cave J, Jauhar S, Young AH. 2023. The effects of reserpine on depression: a systematic review. J. Psychopharmacol. 37: 248-260.
- Diouf PN, Stevanovic T, Cloutier A. 2009. Study on chemical composition, antioxidant and anti-inflammatory activities of hot water extract from Picea mariana bark and its proanthocyanidin-rich fractions. Food Chem. 113: 897-902.
- Zhang LL, Yang ZY, Fan G, Ren JN, Yin KJ, Pan SY. 2019. Antidepressant-like effect of Citrus sinensis (L.) Osbeck essential oil and its main component limonene on mice. J. Agric. Food Chem. 67: 13817-13828.
- Weston-Green K, Clunas H, Jimenez Naranjo C. 2021. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: discovering novel therapeutics in the flavours and fragrances of cannabis. Front. Psychiatry 12: 583211.
- Shinjyo N, Waddell G, Green J. 2020. Valerian root in treating sleep problems and associated disorders-A systematic review and meta-analysis. J. Evid. Based.Integr. Med. 25: 2515690X20967323.
- Masuo Y, Satou T, Takemoto H, Koike K. 2021. Smell and stress response in the brain: review of the connection between chemistry and neuropharmacology. Molecules (Basel, Switzerland) 26: 2571.
- Mitic M, Lazarevic-Pasti T. 2021. Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer's disease lead to depression? Expert Opin. Drug Metab. Toxicol. 17: 841-856.
- Siqueira AA, Cunha AF, Marques GLM, Felippe ISA, Minassa VS, da Silva Gramelich TC, et al. 2019. Atropine counteracts the depressive-like behaviour elicited by acute exposure to commercial chlorpyrifos in rats. Neurotoxicol. Teratol. 71: 6-15.
- Kolar D. 2021. Scopolamine as a potential treatment option in major depressive disorder-A literature review. Isr. J. Psychiatry. 58: 48-53.
- Drevets WC, Bhattacharya A, Furey ML. 2020. The antidepressant efficacy of the muscarinic antagonist scopolamine: past findings and future directions. Adv. Pharmacol. 89: 357-386.